Business Description
BL Pharmtech Corp
ISIN : KR7065170003
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.3 | |||||
Beneish M-Score | -4.9 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -32.2 | |||||
3-Year EBITDA Growth Rate | 0.5 | |||||
3-Year EPS without NRI Growth Rate | 6.6 | |||||
3-Year Book Growth Rate | -22.5 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.43 | |||||
9-Day RSI | 64.44 | |||||
14-Day RSI | 64.17 | |||||
6-1 Month Momentum % | -1.41 | |||||
12-1 Month Momentum % | -20.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.39 | |||||
Quick Ratio | 3.39 | |||||
Days Sales Outstanding | 530.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 28.75 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 175.82 | |||||
Operating Margin % | -68.36 | |||||
Net Margin % | -23.34 | |||||
FCF Margin % | -29.2 | |||||
ROE % | -4.64 | |||||
ROA % | -1.84 | |||||
ROIC % | -5.5 | |||||
ROC (Joel Greenblatt) % | -37.11 | |||||
ROCE % | -24.37 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 9.85 | |||||
PS Ratio | 8.53 | |||||
PB Ratio | 1.64 | |||||
Price-to-Tangible-Book | 1.64 | |||||
Price-to-Free-Cash-Flow | 6.63 | |||||
Price-to-Operating-Cash-Flow | 6.37 | |||||
EV-to-EBIT | -4.42 | |||||
EV-to-EBITDA | -5.35 | |||||
EV-to-Revenue | 8.36 | |||||
EV-to-FCF | 5.31 | |||||
Price-to-Median-PS-Value | 6.71 | |||||
Price-to-Graham-Number | 0.85 | |||||
Price-to-Net-Current-Asset-Value | 7.5 | |||||
Earnings Yield (Greenblatt) % | -22.63 | |||||
FCF Yield % | 15.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BL Pharmtech Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 5,967.595 | ||
EPS (TTM) (â‚©) | -15.102 | ||
Beta | 1.08 | ||
Volatility % | 50.88 | ||
14-Day RSI | 64.17 | ||
14-Day ATR (â‚©) | 43.539732 | ||
20-Day SMA (â‚©) | 516.65 | ||
12-1 Month Momentum % | -20.23 | ||
52-Week Range (â‚©) | 322 - 930 | ||
Shares Outstanding (Mil) | 88.97 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BL Pharmtech Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BL Pharmtech Corp Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
BL Pharmtech Corp Frequently Asked Questions
What is BL Pharmtech Corp(XKRX:065170)'s stock price today?
When is next earnings date of BL Pharmtech Corp(XKRX:065170)?
Does BL Pharmtech Corp(XKRX:065170) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |